|Posted:||September 13, 2022 01:44 PM|
|From:||Representative Jeanne McNeill and Rep. Mike Zabel|
|To:||All House members|
|Subject:||$35 Cap on Insulin Prices|
|Insulin costs tripled between 2002 and 2013. Tragic reports of deaths from insulin rationing have become all too common as people grapple with the skyrocketing price of this drug.
We will be reintroducing a new version of our bill, House Bill 460 of the 2021-2022 Legislative Session, to cap insulin prices for patients. However, while our last bill capped the amount an insured patient could spend per 30-day supply at $100, our new version of the bill will cap the price at $35 per 30-day supply. This exact proposal has already passed the U.S. House of Representatives and came just three votes shy of the U.S. Senate’s 60-vote threshold for such legislation.
Capping insulin costs for patients is bipartisan. Twenty-one states already cap insulin co payments. These include states as blue as New York and Maryland and as red as Texas and Oklahoma. Capping insurance costs also has across-the-aisle support in Congress. In both the House and Senate, Republicans have joined Democrats in voting to cap insulin prices at $35 for patients.
Please join us in co-sponsoring this important legislation so people can have access to affordable lifesaving drugs as soon as possible.
Introduced as HB2878